
Sep 9, 2026
LUMA Vision Secures FDA Clearance Advancing Procedural Intelligence as the Foundation of the Cardiac Lab of the Future
Latest Clearance Expands VERAFEYE's Capabilities as the Company Prepares for Commercial Launch in Early 2027DUBLIN, Sept. 9, 2026 /PRNewswire/ -- LUMA Vision, a medtech company transforming minimally invasive cardiac procedures, today announced FDA clearance expanding the capabilities of VERAFEYE, its procedural intelligence platform. The news marks another significant step toward the company's vision for the cardiac lab of the future, where imaging, visualization, navigation, and guidance opera



